In the United States, 33%-50% of patients receiving an allogeneic transplant develop acute GVHD. There are 5 types of immune-mediated cytopenias, each with provisional diagnostic criteria. Nurses have a critical role in managing cGVHD-related serositis, including patient assessment, direct care, and education. Researchers presented real-world data on the cGVHD treatment during the EHA 2024 Congress. Certain predictive markers may help identify patients who "experience significant benefits" from upfront use of this therapy. Since TAC levels must remain in a therapeutic range, oncology nurses often draw blood levels before the morning dose. Mairéad Ní Chonghaile, RGN, BNS, MSc, speaks about the importance of staying current on the latest updates in the field. Although the term “atypical cGVHD” is imperfect, it describes a form of cGVHD that doesn’t fit neatly into classic ... Nearly all patients in the study had steroid-dependent chronic GVHD, and nearly half had severe chronic GHVD. A new study shows why it's important for nurses to help optimize health care resource availability for certain patients. More than half of the patients receiving belumosudil were able to have a corticosteroid dose reduction. Research suggests that patients are asked to make transplant decisions based on variable information. Jamie Oliva, PhD, ANP-BC, FNAP, BMTCN, discusses results she presented at the 49th Annual ONS Congress. A study of children with chronic GVHD showed that none reported having positive experiences at school. Researchers evaluated oral suspensions because patients with certain types of GVHD may have difficulty swallowing a tablet. Researchers surveyed nurses at centers with a high volume of allogeneic HSCT. The GI tract, commonly called “the gut,” is a frequent target of GVHD, in particular aGVHD. Dealing with the long-term, life-altering, uncomfortable symptoms of chronic GVHD can be difficult to accept. Mary Mansour Riwes, DO, explains what she saw as the important news in GVHD at the 2024 Tandem Meetings. Mary Mansour Riwes, DO, speaks about research on the topic that she presented at the 2024 Tandem Meetings.